We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Circadian Rhythm of Blood Lactate

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01303848
First Posted: February 25, 2011
Last Update Posted: May 2, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
State University of New York - Downstate Medical Center
Information provided by (Responsible Party):
Axel Schlitt, Martin-Luther-Universität Halle-Wittenberg
  Purpose
To elucidate whether blood lactate, lipid transfer proteins and PPARs/CLOCK/Bal1 have a circadian rhythm

Condition Intervention
Healthy Other: Blood Sampling

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Circadian Rhythm of Blood Lactate, Lipid Transferproteins and Genetic Markers (PPARs, CLOCK, Bmal1)

Further study details as provided by Axel Schlitt, Martin-Luther-Universität Halle-Wittenberg:

Primary Outcome Measures:
  • Circadian rhythm of blood lactate [ Time Frame: 5 months ]
    Blood samples


Secondary Outcome Measures:
  • Circadian rhythm of Lipid transfer proteins [ Time Frame: 5 months ]
    Blood

  • Circadian rhythm of PPARs, CLOCK and Bal1 [ Time Frame: 5 months ]
    Blood


Enrollment: 30
Study Start Date: February 2011
Study Completion Date: May 2012
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Healthy probands
Healthy probands, age between 18 and 40 years
Other: Blood Sampling
Blood Sampling over 24 hours

Detailed Description:
Blood will be drawn fasting and then every hour over a period of 24 hours in 30 healthy probands.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
30 healthy probands
Criteria

Inclusion Criteria:

  • Age between 18 and 40 years old

Exclusion Criteria:

  • Inability/unwilling to give written informed consent
  • Chronic disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01303848


Locations
Germany
University Clinic Halle, Martin Luther-University Halle-Wittenberg
Halle (Saale), Germany, 06120
Sponsors and Collaborators
Martin-Luther-Universität Halle-Wittenberg
State University of New York - Downstate Medical Center
Investigators
Principal Investigator: Axel Schlitt, MD Department of Medicine III, University Clinic Halle, Martin Luther-University Halle-Wittenberg
  More Information

Responsible Party: Axel Schlitt, PD Dr. med. habil., Martin-Luther-Universität Halle-Wittenberg
ClinicalTrials.gov Identifier: NCT01303848     History of Changes
Other Study ID Numbers: UKH2011Sport1
First Submitted: February 24, 2011
First Posted: February 25, 2011
Last Update Posted: May 2, 2012
Last Verified: May 2012

Keywords provided by Axel Schlitt, Martin-Luther-Universität Halle-Wittenberg:
Blood lactate
Lipid transfer proteins
Lactate
PLTP
CETP
PPARs
CLOCk
Bal1